Prohibited actions with respect to a federally qualified health center

(1) As used in this section, "federally qualified health center": (a) means the same as that term is defined in 42 U.S.C. Sec. 1395x(aa)(4); and (b) includes the pharmacy or pharmacies that are operated by or contract with a federally qualified health center described in Subsection (1)(a) to dispense drugs purchased through the federally qualified health center. (2) This section applies to a contract entered into or renewed on or after January 1, 2022, between an insurer and a pharmacy described in Subsection (1)(b). (3) An insurer may not vary the amount that the insurer reimburses to a federally qualified health center for a drug on the basis of whether: (a) the drug is a 340B drug; or (b) the pharmacy is a 340B entity. (4) Subsection (3) does not apply to a drug reimbursed, directly or indirectly, by the Medicaid program. (5) An insurer or an insurer's pharmacy service entity may not: (a) on the basis that a federally qualified health center participates, directly or through a contractual arrangement, in the 340B drug discount program: (i) assess a fee, charge-back, or other adjustment on a federally qualified health center; (ii) restrict access to the insurer's pharmacy network; (iii) require the federally qualified health center to enter into a contract with a specific pharmacy to participate in the insurer's pharmacy network; (iv) create a restriction or an additional charge on a patient who chooses to receive drugs from a federally qualified health center; or (v) create any additional requirements or restrictions on the federally qualified health center; or (b) require a claim for a drug to include a modifier to indicate that the drug is a 340B drug unless the claim is for payment, directly or indirectly, by the Medicaid program.